Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Weather
96 NC counties and 1 VA county are under alert, including Wake, Cumberland, Durham, Johnston, and Orange counties.
Closings
32 closings/delays reported.
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Puretech Health Plc ADR
(NQ:
PRTC
)
21.25
+0.56 (+2.71%)
Streaming Delayed Price
Updated: 2:46 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
16,414
Open
21.63
Bid (Size)
13.00 (5)
Ask (Size)
30.00 (6)
Prev. Close
20.69
Today's Range
21.16 - 22.11
52wk Range
17.08 - 34.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Schizophrenia Treatment Revolution: FDA Approves Bristol Myers Squibb' Cobenfy As New Class Of Treatment In More Than 3 Decades
Today 7:56 EDT
Bristol Myers Squibb's Cobenfy has been approved by the FDA as the first new treatment for schizophrenia in decades. The medication introduces a new approach by targeting M1 and M4 receptors without...
Via
Benzinga
Exposures
Product Safety
PureTech-Invented KarXT Receives U.S. Food and Drug Administration Approval for the Treatment of Schizophrenia in Adults
Today 2:00 EDT
From
PureTech Health plc
Via
Business Wire
Performance
YTD
-15.00%
-15.00%
1 Month
-15.00%
-15.00%
3 Month
-13.27%
-13.27%
6 Month
-25.44%
-25.44%
1 Year
-5.56%
-5.56%
More News
Read More
Rubrik Reports Q2 Results, Joins Ionis Pharmaceuticals, Hewlett Packard Enterprise And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
September 10, 2024
Via
Benzinga
PureTech Founded Entity Vor Bio Announces New Clinical Data Validating Approach of Using Shielded Transplants to Deliver Targeted Therapies
September 06, 2024
From
PureTech Health plc
Via
Business Wire
Boeing, Dyne Therapeutics And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
September 03, 2024
Via
Benzinga
PureTech Health plc – Half-Year Report
August 28, 2024
From
PureTech Health plc
Via
Business Wire
Galapagos, XPeng, CorMedix And Other Big Stocks Moving Higher On Monday
August 26, 2024
Via
Benzinga
PureTech Appoints Michele Holcomb, PhD, to Board of Directors
August 22, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Health: Notice of Half-Yearly Results
August 21, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Seaport Therapeutics Appoints David Wheadon, M.D., to its Board of Directors
August 13, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Expands Leadership Team and Appoints Head of Commercial
July 23, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Health: Completion of Tender Offer & Total Voting Rights
June 24, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Health: Results of the Tender Offer
June 24, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Announces Change of Board Role
June 20, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Seaport Therapeutics Appoints Seasoned Executives to Management Team
June 18, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Health: Results of Annual General Meeting
June 13, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Health: Result of General Meeting
June 06, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Akili Interactive and Virtual Therapeutics Announce Entering Into Definitive Merger Agreement to Establish Leading Digital Health Company
May 29, 2024
From
PureTech Health plc
Via
Business Wire
PureTech to Present at the Jefferies Global Healthcare Conference
May 23, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Vedanta Biosciences Enrolls First Patient in Pivotal Phase 3 RESTORATiVE303 Study of VE303 for the Prevention of Recurrent C. difficile Infection
May 21, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Health: Launch of Proposed $100 Million Tender Offer at 250 Pence Per Ordinary Share
May 20, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting
May 09, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments
May 07, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Announces Annual Results for Year Ended December 31, 2023
April 25, 2024
From
PureTech Health plc
Via
Business Wire
PureTech Health: Notice of Results
April 18, 2024
From
PureTech Health plc
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.